英國HIV協(xié)會(BHIVA)和歐洲艾滋病臨床學會(EACS)的官方期刊。一個新的廣泛的基礎上的研究人員和臨床醫(yī)生負責治療艾滋病毒陽性患者。該雜志將以原創(chuàng)文章、案例報告和評論為特色。還將包括一個討論倫理問題及其對臨床管理的影響的常規(guī)章節(jié)。所有文章都將經(jīng)過同行評審。爆發(fā)以來的艾滋病毒流行的論文數(shù)量寫在這個問題上已經(jīng)上升指數(shù)和臨床醫(yī)生試圖治療HIV-seropositive患者面臨一系列令人眼花繚亂的信息包括病毒學免疫學和流行病學和試圖解釋患者最佳治療的影響。因此我們希望產(chǎn)生一個基本的科學》雜志上提出了一個格式,將能為醫(yī)生治療HIV-seropositive患者整個歐洲,在適當?shù)臅r候將被視為一個重要的出版物的最新研究和臨床發(fā)現(xiàn)艾滋病毒藥物。

The official journal of the British HIV Association (BHIVA) and the European AIDS Clinical Society (EACS). A new broad based journal for researchers and clinicians with responsibility for treating HIV seropositive patients. The Journal will feature original articles case reports and reviews. A regular section addressing ethical issues and their implications for clinical management will also be included. All articles will be peer-reviewed. Since the onset of the HIV epidemic the number of papers written on this subject has risen exponentially and clinicians trying to treat HIV-seropositive patients are faced with a bewildering array of information including virology immunology and epidemiology and have to try to explain to their patients the implications of this for optimum treatment. We therefore hope to produce a journal in which basic science is presented in a format that will be readily accessible to physicians treating HIV-seropositive patients across Europe and which in due course will be seen as one of the premier publications for the latest research and clinical findings in HIV medicine.